(Q35082154)

6 August 2017

1 reference

title

Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor (English)

1 reference

6 August 2017

Douglas J Sheffler

1

1 reference

PubMed ID

12628350

6 August 2017

Bryan L Roth

series ordinal

2

1 reference

PubMed ID

12628350

6 August 2017

language of work or name

1 reference

1 March 2003

1 reference

Trends in Pharmacological Sciences

6 August 2017

1 reference

6 August 2017

24

1 reference

6 August 2017

3

1 reference

6 August 2017

107-109

1 reference

Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Salvia divinorum and salvinorin A: new pharmacologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Psychotomimesis mediated by kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

The therapeutic role of naltrexone in negative symptom schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Opioid receptor density changes in Alzheimer amygdala and putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

Studies ofSalvia divinorum (Lamiaceae), an Hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900027-0

7 January 2021

10.1016/S0165-6147(03)00027-0

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12628350